3F-PCP

3-Fluoro-PCP (other names: 3F-PCP, 3-Fl-PCP, 3′-F-PCP, 3-fluoro Phencyclidine, Piperidine) is a designer substance of the arylcyclohexylamine family, which has a dissociative effect.

History

3F-PCP is known as a designer drug and was first discovered in the EU in 2020.

Chemistry

3-Fluoro-PCP is a fluorinated homologue of PCP.

Pharmacolgy

3F-PCP is relatively new and little studied, there are few data on its pharmacological and toxicological properties.
3-Fluoro-PCP is an NMDA receptor antagonist, as well as a dopamine reuptake inhibitor.

Effects

This drug may produce both an arousal-stimulant and a sedative state, depending on the dosage. In high doses, it may cause dissociative effects.

Legal status

Canada Schedule I,
Germany NpSG, Industrial and scientific use only,
United Kingdom Class B,
Banned in Hungary.
In some countries where PCP analogs are controlled by law, it may not be legal.